Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Melphalan × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Myelodysplastic Syndromes 5 Multiple Myeloma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3 Hematologic Neoplasms 3 Neuroblastoma 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Hodgkin Disease 2 Hematologic Diseases 2 Venentoclax 1 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Rasmussen subacute encephalitis 1 Primary Myelofibrosis 1 Preleukemia 1 Precancerous Conditions 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Osteosarcoma 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasms by Histologic Type 1 Neoplasms 1

Interventions

Nivolumab 18 cabozantinib 14 Magnetic Resonance Spectroscopy 14 Specimen Handling 12 Ipilimumab 12 pembrolizumab 11 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 trastuzumab deruxtecan 1 temsirolimus 1 sitravatinib 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡